Utterberg David S 4
4 · NxStage Medical, Inc. · Filed Dec 11, 2012
Insider Transaction Report
Form 4
Utterberg David S
Director10% Owner
Transactions
- Sale
Common Stock
2012-12-10$11.06/sh−12,602$139,418→ 4,094,348 total - Sale
Common Stock
2012-12-07$11.02/sh−11,347$125,070→ 4,106,950 total - Sale
Common Stock
2012-12-11$11.50/sh−37,311$429,248→ 4,057,037 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2010, amended on March 11, 2011, and further amended on August 15, 2012.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.00 to $11.14. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.00 to $11.20. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.20 to $11.66. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.